NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-150-2022-0-PCT-02 Compositions And Methods For Preventing And/or Treating Filarial Disease PCT PCT PCT/US2019/049869 Expired
NIAID E-150-2022-0-US-06 Compositions And Methods For Preventing And/or Treating Filarial Disease US National Stage 17/273,212 Pending
NIAID E-150-2022-0-EP-05 Compositions And Methods For Preventing And/or Treating Filarial Disease EP National Stage 19857011.1 Pending
NIAID E-150-2022-0-CA-04 Compositions And Methods For Preventing And/or Treating Filarial Disease CA National Stage 3110571 Pending
NCI E-230-2020-0-PCT-02 Recurrence Gene Signature Across Multiple Cancer Types PCT PCT PCT/US2019/049688 Expired
NIBIB E-006-2016-0-US-06 SYSTEMS AND METHODS FOR INSTANT TOTAL INTERNAL REFLECTION FLUORESCENCE/ STRUCTURED ILLUMINATION MICROSCOPY US CON 16/559,805 10914933 Abandoned PDF
NIAID E-178-2014-2-US-04 Self-Assembling Bi-component Nanoparticles For Display Of Co-assembled Trimeric Antigens US DIV 16/557,894 11459360 Issued PDF
NCATS E-084-2020-0-US-01 Preparation Of Benzene-1,4-disulfonamide Derivatives Useful As Therapeutic TRPML1 Receptor Modulators US 62/894,289 Abandoned
NIAID E-048-2020-0-US-01 COMPOSITIONS INCLUDING IGG Fe MUTATIONS AND USES THEREOF US 62/894,488 Abandoned
NCI E-132-2012-0-US-11 Altering the lmmundominance Hierarchy Using a DNA Vaccine Expressing Conserved Regions US DIV 16/554,133 11167025 Issued PDF
NINDS E-252-2016-1-US-03 DIAGNOSING COL6-RELATED DISORDERS AND METHODS FOR TREATING SAME US National Stage 16/315,278 11655470 Issued PDF
NIAID E-181-2016-0-US-03 ZIKA VIRUS VACCINES US National Stage 16/334,099 10898566 Issued PDF
NCI E-139-2018-0-AU-04 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING AU National Stage 2019325658 Issued
NCI E-146-2018-0-PCT-02 METHOD FOR TREATING GLIOBLASTOMA PCT PCT PCT/US2019/048040 Expired
NCI E-139-2018-0-PCT-02 Water Soluble Novel Cyanine Fluorophore With Tunable Optical Properties Between Near IR And SWIR Region For In Vivo Imaging PCT PCT PCT/US2019/047972 Expired
NCI E-146-2018-0-CN-04 CAR T-cells Targeting CAIX For Glioblastoma Therapy CN National Stage 201980046258.6 Abandoned
NCI E-139-2018-0-EP-06 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING EP National Stage 19765398.3 Pending
NCI E-139-2018-0-JP-07 Water Soluble Novel Cyanine Fluorophore With Tunable Optical Properties Between Near IR And SWIR Region For In Vivo Imaging JP National Stage 2021-509873 Abandoned
NCI E-139-2018-0-CA-05 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING CA National Stage 3106249 Pending
CC E-183-2016-0-US-04 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS US National Stage 16/488,127 11200667 Issued PDF
NCI E-254-2005-2-US-26 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS US DIV 16/547,039 11339198 Issued PDF
NEI E-077-2018-0-PCT-02 METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS PCT PCT PCT/US2019/047504 Expired
NEI E-077-2018-0-CN-03 METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS CN National Stage 201980061762.3 Pending
NINDS E-088-2018-1-KR-09 Amti-HERV-K Envelope Antibody and Uses Thereof KR National Stage 10-2019-7024261 Issued
CC E-183-2016-0-JP-09 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING
RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE
SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS 		JP National Stage 2019-545291 Issued
NHLBI E-342-2013-0-US-06 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US DIV 16/544,381 11072778 Issued PDF
NCI E-248-2020-0-US-01 Protein Panels For The Early Diagnosis/Prognosis Of Aggressive Prostate Cancer US 62/888,890 Abandoned
NHLBI E-134-2017-3-KR-12 APOC-II MIMETIC PEPTIDES KR National Stage 10-2019-7024024 Issued
NIDDK E-132-2018-1-PCT-01 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5’-NUCLEOTIDASE INHIBITORS PCT PCT PCT/US2019/046931 Expired
NCI E-298-2016-0-US-04 EFFICIENT CELL FREE PRODUCTION OF PAPILLOMAVIRUS GENE TRANSFER VECTORS US National Stage 16/486,626 Abandoned
NLM E-107-2010-2-US-27 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/541,857 10774373 Issued PDF
NCI E-230-2012-0-MX-16 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 MX DIV MX/a/2019/009641 Issued
NCI E-063-2017-0-AU-03 DENOISING OF DYNAMIC MAGNETIC RESONANCE SPECTROSCOPIC
IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN 		AU National Stage 2018221015 Issued
NCI E-063-2017-0-US-07 Denoising Of Dynamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations In The Kinetic Domain US National Stage 16/485,772 Pending
NIDCR E-175-2015-1-EP-06 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone EP DIV 19191545.3 Abandoned
NIAID E-038-2017-1-US-03 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US National Stage 16/485,354 11021535 Issued PDF
NCI E-126-2019-0-US-01 T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY US 62/883,927 Abandoned
NCI E-198-2018-0-CN-05 High Affinity Monoclonal Antibodies Targeting Glypican-2 For Treating Childhood Cancers CN National Stage 201980053942.7 Issued
NCI E-084-2016-0-US-18 Methods Of Preparing T Cells For T Cell Therapy US CON 16/533,109 11723923 Issued PDF
NCI E-230-2012-0-AU-15 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2019213329 Issued
NCI E-198-2018-0-PCT-02 High Affinity Monoclonal Antibodies Targeting Glypican-2 For Treating Childhood Cancers PCT PCT PCT/US2019/045338 Expired
NCI E-198-2018-0-EP-06 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF EP National Stage 19759784.2 Pending
NCI E-198-2018-0-AU-03 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF AU National Stage 2019317565 Pending
NCI E-198-2018-0-CA-04 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF CA National Stage 3106544 Pending
NIAID E-050-2018-0-PCT-02 Nipah Virus Immunogens And Their Use PCT PCT PCT/US2019/045110 Expired
NIAID E-050-2018-0-CN-04 Nipah Virus Immunogens And Their Use CN National Stage 201980051936.8 Pending
NIAID E-050-2018-0-EP-05 Nipah Virus Immunogens And Their Use EP National Stage 19755481.9 Pending
NIAID E-050-2018-0-IN-06 Nipah Virus Immunogens And Their Use IN National Stage 202117006653 Pending
NIAID E-050-2018-0-AU-03 Nipah Virus Immunogens And Their Use AU National Stage 2019315602 Pending
NCI E-034-2020-0-US-02 KRAS Peptide Vaccine Compositions And Method Of Use US National Stage 16/483,332 11771749 Issued PDF